Targeting APLN/APLNR improves antiangiogenic efficiency and blunts proinvasive side effects of VEGFA/VEGFR2 blockade in glioblastoma

Giorgia Mastrella, Mengzhuo Hou, Min Li, Veit M. Stoecklein, Nina Zdouc, Marie N.M. Volmar, Hrvoje Miletic, Soren Reinhard, Christel C. Herold-Mende, Susanne Kleber, Katharina Eisenhut, Gaetano Gargiulo, Michael Synowitz, Angelo L. Vescovi, Patrick N. Harter, Josef M. Penninger, Ernst Wagner, Michel Mittelbronn, Rolf Bjerkvig, Dolores HambardzumyanUlrich Schuller, Jorg Christian Tonn, Josefine Radke, Rainer Glass, Roland E. Kalin*

*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

57 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Targeting APLN/APLNR improves antiangiogenic efficiency and blunts proinvasive side effects of VEGFA/VEGFR2 blockade in glioblastoma'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology